Paulson Builds Stake in Allergan; Supports Valeant

HFA Padded
Mark Melin
Published on
Updated on

The heat is being applied to Allergan, Inc. (NYSE:AGN) by a hedge fund executive other than Pershing Square’s William Ackman. Reuters is reporting that John Paulson is among the top 15 holders of Allergan stock. Paulson has built an exposure to Allergan Paulson’s hedge fund, Paulson & Company, has build an exposure to Allergan, Inc. (NYSE:AGN) of more than six million shares – shares it plans to vote in favor of an unsolicited buyout offer from Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX), Reuters is reporting, citing “people familiar with the matter.” At issue is a vote to replace the existing…

This content is exclusively for paying members of Hedge Fund Alpha

Log In

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!

HFA Padded

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

Comments are closed.